Natural Solutions Radio header image


AIDS drug Prezista performs well in new study

By Will Dunham

WASHINGTON, April 4 (Reuters) - The new AIDS drug Prezista performed very well in halting the onslaught of the human immunodeficiency virus in people with advanced infection, a study published on Wednesday showed.

The success of the drug, made by the Johnson & Johnson <JNJ.N> unit Tibotec Pharmaceuticals Ltd., comes at a time of acute need for new AIDS therapies because many existing drugs are failing as HIV mutates to thwart them.

It is in a class of drugs called protease inhibitors that are designed suppress HIV and prevent it from repl


Africa: HIV Babies May Grow Up Unaware of Their Infection

Kerry Cullinan

Far more African babies infected with HIV by their mothers may survive to puberty than previously thought - but the health services are ill-equipped to deal with HIV positive teens who need special care.

This is according to a study conducted by researchers based at the Connaught Clinic in Harare, Zimbabwe that was published this week in Clinical Infectious Diseases.


Prostitutes, Gene Flaw Spur Pfizer Hunt for AIDS Drug (Update2)

By Andrea Gerlin

March 1 (Bloomberg) -- In 1996, scientists solved a mystery surrounding certain gay men who were immune to AIDS. This year, Pfizer Inc. will sell the first drug based on that discovery.

The U.S. and European researchers, writing in several science journals, said a small group of Caucasian gay men carry a gene mutation that provides natural protection against HIV, the virus that causes AIDS. This week, culminating an 11-year race among three drugmakers, Pfizer released successful studies of a new pill specifically designed to mimic the gene defect.


Three new drugs promise options for HIV patients

LOS ANGELES -- Three experimental HIV drugs with two entirely new mechanisms for attacking viruses promise to spur a change in how doctors treat the virus that causes AIDS, helping thousands of patients who have stopped responding to previous medicines.


Mute Child Sparks Mom to Swap South African Cures for AIDS Drug

By Vernon Wessels and Mike Cohen

Feb. 27 (Bloomberg) -- Thandi Mabaso refused to take drugs when she and her newborn were diagnosed with HIV. She had heard they were dangerous on the car-battery-powered radio in her home in South Africa's KwaZulu-Natal province.

Mabaso relented last year when, at almost 3, her daughter wasn't walking or talking after treatment with traditional herbal remedies and vitamins. Her girl has gained more than 2 kilograms (4.4 pounds) and now enjoys playing among the goats and chickens that roam near the corn fields outside their front door.


Canada Joins Gates in AIDS Vaccine Fight


The Associated Press
Tuesday, February 20, 2007

TORONTO -- The Canadian government and Bill Gates announced an initiative Tuesday to establish a research institute to develop an AIDS vaccine, committing a total of $119 million to the project.

Prime Minister Stephen Harper said his government has pledged $95.3 million to a new fund called the Canadian HIV Vaccine Initiative, while the Bill and Melinda Gates Foundation has promised up to $24 million.


Gambian President Holds Sessions to 'Cure AIDS'

By Kari Barber
Banjul, Gambia
21 February 2007

In a continent suffering from the AIDS epidemic, Gambian President Yayah Jammeh's claims of a cure for the disease are alarming public health workers already struggling against faith-healers dispensing herbal remedies. The biggest concern is that he requires patients to cease anti-retroviral drugs. Kari Barber traveled to Banjul to see Mr. Jammeh perform his self-proclaimed AIDS treatment and has this report for VOA.


Study: Treating Genital Herpes May Slow AIDS Progression

By Jessica Berman
22 February 2007

An international team of researchers has discovered a way that may make it possible to slow the progression of HIV virus in women who also suffer from genital herpes. The investigators found that treating such women with an inexpensive drug for genital herpes reduced the amount of AIDS virus in their blood. VOA's Jessica Berman reports.